{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:25:04Z","timestamp":1786116304027,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03283-7","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:37:09Z","timestamp":1777419429000},"page":"1600-1610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of an Anticoagulation Management Service\u2013Led Annual Review on Antiplatelet Use and Gastrointestinal Bleeding Prophylaxis in Ambulatory Patients on Background Direct Oral Anticoagulants"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2180-9020","authenticated-orcid":false,"given":"Chau","family":"Hoang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"DeiCicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan","family":"McNicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devan","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Zaiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"20","key":"3283_CR1","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1001\/jama.2016.16201","volume":"316","author":"N Shehab","year":"2016","unstructured":"Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidle NJ, Budnitz DS (2016) US Emergency Department Visits for Outpatient Adverse Drug Events, 2013\u20132014. JAMA 316(20):2115\u20132125. https:\/\/doi.org\/10.1001\/jama.2016.16201","journal-title":"JAMA"},{"issue":"1","key":"3283_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.advms.2017.06.005","volume":"63","author":"E Michniewicz","year":"2018","unstructured":"Michniewicz E, Mlodawska E, Lopatowska P, Tomaszuk-Kazberuk A, Malyszko J (2018) Patients with atrial fibrillation and coronary artery disease - Double trouble. Adv Med Sci 63(1):30\u201335. https:\/\/doi.org\/10.1016\/j.advms.2017.06.005","journal-title":"Adv Med Sci"},{"issue":"6","key":"3283_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1161\/CIRCULATIONAHA.118.036248","volume":"139","author":"N van Rein","year":"2019","unstructured":"van Rein N, Heide-J\u00f8rgensen U, Lijfering WM, Dekkers OM, S\u00f8rensen HT, Cannegieter SC (2019) Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy. Circulation 139(6):775\u2013786. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036248","journal-title":"Circulation"},{"issue":"5","key":"3283_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jacc.2020.09.011","volume":"77","author":"DJ Kumbhani","year":"2021","unstructured":"Kumbhani DJ, Cannon CP, Beavers CJ et al (2021) 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or with Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 77(5):629\u2013658. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.011","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"3283_CR5","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","volume":"148","author":"SS Virani","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV et al (2023) 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients with Chronic Coronary Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 148(9):e9\u2013e119. https:\/\/doi.org\/10.1161\/CIR.0000000000001168","journal-title":"Circulation"},{"key":"3283_CR6","doi-asserted-by":"publisher","unstructured":"Angiolillo DJ, Bhatt DL, Cannon CP et al (2021) Antithrombotic Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update. Circulation 143(6):583\u2013596. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050438\\","DOI":"10.1161\/CIRCULATIONAHA.120.050438\\"},{"issue":"36","key":"3283_CR7","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC et al (2024) 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J 45(36):3415\u20133537. https:\/\/doi.org\/10.1093\/eurheartj\/ehae177","journal-title":"Eur Heart J"},{"issue":"5","key":"3283_CR8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","volume":"154","author":"GYH Lip","year":"2018","unstructured":"Lip GYH, Banerjee A, Boriani G et al (2018) Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest 154(5):1121\u20131201. https:\/\/doi.org\/10.1016\/j.chest.2018.07.040","journal-title":"Chest"},{"issue":"1","key":"3283_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL et al (2024) 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 149(1):e1\u2013e156. https:\/\/doi.org\/10.1161\/CIR.0000000000001193","journal-title":"Circulation"},{"issue":"9872","key":"3283_CR10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","volume":"381","author":"WJ Dewilde","year":"2013","unstructured":"Dewilde WJ, Oirbans T, Verheugt FW et al (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381(9872):1107\u20131115. https:\/\/doi.org\/10.1016\/S0140-6736(12)62177-1","journal-title":"Lancet"},{"issue":"16","key":"3283_CR11","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","volume":"377","author":"CP Cannon","year":"2017","unstructured":"Cannon CP, Bhatt DL, Oldgren J et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377(16):1513\u20131524. https:\/\/doi.org\/10.1056\/NEJMoa1708454","journal-title":"N Engl J Med"},{"issue":"16","key":"3283_CR12","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","volume":"380","author":"RD Lopes","year":"2019","unstructured":"Lopes RD, Heizer G, Aronson R et al (2019) Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med 380(16):1509\u20131524. https:\/\/doi.org\/10.1056\/NEJMoa1817083","journal-title":"N Engl J Med"},{"issue":"1","key":"3283_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/europace\/euz259","volume":"22","author":"TS Potpara","year":"2020","unstructured":"Potpara TS, Mujovic N, Proietti M et al (2020) Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials. Europace 22(1):33\u201346. https:\/\/doi.org\/10.1093\/europace\/euz259","journal-title":"Europace"},{"issue":"3","key":"3283_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","volume":"140","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R et al (2019) Defining high bleeding risk in patients undergoing percutaneous coronary intervention. Circulation 140(3):240\u2013261","journal-title":"Circulation"},{"issue":"13","key":"3283_CR15","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.1161\/CIR.0000000000001309","volume":"151","author":"SV Rao","year":"2025","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M et al (2025) 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients with Acute Coronary Syndromes: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 151(13):e771\u2013e862. https:\/\/doi.org\/10.1161\/CIR.0000000000001309","journal-title":"Circulation"},{"issue":"12","key":"3283_CR16","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","volume":"381","author":"S Yasuda","year":"2019","unstructured":"Yasuda S, Kaikita K, Akao M et al (2019) Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med 381(12):1103\u20131113. https:\/\/doi.org\/10.1056\/NEJMoa1904143","journal-title":"N Engl J Med"},{"issue":"22","key":"3283_CR17","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1056\/NEJMoa2407362","volume":"391","author":"MS Cho","year":"2024","unstructured":"Cho MS, Kang DY, Ahn JM et al (2024) Edoxaban antithrombotic therapy for atrial fibrillation and stable coronary artery disease. N Engl J Med 391(22):2075\u20132086. https:\/\/doi.org\/10.1056\/NEJMoa2407362","journal-title":"N Engl J Med"},{"issue":"11","key":"3283_CR18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jacc.2024.12.030","volume":"85","author":"S Rashedi","year":"2025","unstructured":"Rashedi S, Keykhaei M, Sato A et al (2025) Anticoagulation and antiplatelet therapy for atrial fibrillation and stable coronary disease: meta-analysis of randomized trials. J Am Coll Cardiol 85(11):1189\u20131203. https:\/\/doi.org\/10.1016\/j.jacc.2024.12.030","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3283_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/j.gastro.2013.02.041","volume":"145","author":"IL Holster","year":"2013","unstructured":"Holster IL, Valkhoff VE, Kuipers EJ, Tjwa ETTL (2013) New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterology 145(1):105\u2013112e15. https:\/\/doi.org\/10.1053\/j.gastro.2013.02.041","journal-title":"Gastroenterology"},{"issue":"11","key":"3283_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365(11):981\u2013992. https:\/\/doi.org\/10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"issue":"10","key":"3283_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883\u2013891. https:\/\/doi.org\/10.1056\/NEJMoa1009638","journal-title":"N Engl J Med"},{"key":"3283_CR22","doi-asserted-by":"publisher","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation [published correction appears in N Engl J Med. 2010;363(19):1877]. N Engl J Med 361(12):1139\u20131151. https:\/\/doi.org\/10.1056\/NEJMoa0905561","DOI":"10.1056\/NEJMoa0905561"},{"issue":"22","key":"3283_CR23","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369(22):2093\u20132104. https:\/\/doi.org\/10.1056\/NEJMoa1310907","journal-title":"N Engl J Med"},{"issue":"8","key":"3283_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/heartjnl-2021-319332","volume":"108","author":"J Komen","year":"2022","unstructured":"Komen J, Potteg\u00e5rd A, Hjemdahl P et al (2022) Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds. Heart 108(8):613\u2013618. https:\/\/doi.org\/10.1136\/heartjnl-2021-319332","journal-title":"Heart"},{"issue":"21","key":"3283_CR25","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1001\/jama.2018.17242","volume":"320","author":"WA Ray","year":"2018","unstructured":"Ray WA, Chung CP, Murray KT et al (2018) Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding. JAMA 320(21):2221\u20132230. https:\/\/doi.org\/10.1001\/jama.2018.17242","journal-title":"JAMA"},{"issue":"10","key":"3283_CR26","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1161\/CIR.0000000000000404","volume":"68","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA et al (2016) 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. J Am Coll Cardiol 68(10):1082. https:\/\/doi.org\/10.1161\/CIR.0000000000000404","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"3283_CR27","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1161\/CIR.0b013e318202f701","volume":"122","author":"NS Abraham","year":"2010","unstructured":"Abraham NS, Hlatky MA, Antman EM et al (2010) ACCF\/ACG\/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American college of cardiology foundation task force on expert consensus documents. Circulation 122(24):2619\u20132633. https:\/\/doi.org\/10.1161\/CIR.0b013e318202f701","journal-title":"Circulation"},{"issue":"5","key":"3283_CR28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5):1093\u20131100","journal-title":"Chest"},{"issue":"2","key":"3283_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11239-021-02551-y","volume":"53","author":"S Meador","year":"2022","unstructured":"Meador S, Dyke S, Togami J, Kuskov B, Burnett AE (2022) Antithrombosis stewardship efforts to de-escalate inappropriate combined therapy in outpatient clinics. J Thromb Thrombolysis 53(2):436\u2013445. https:\/\/doi.org\/10.1007\/s11239-021-02551-y","journal-title":"J Thromb Thrombolysis"},{"key":"3283_CR30","doi-asserted-by":"publisher","first-page":"100165","DOI":"10.1016\/j.ahjo.2022.100165","volume":"17","author":"BJ Domaleczny","year":"2022","unstructured":"Domaleczny BJ, Lewis SJ, Richardson JL, Eid HR (2022) Impact of pharmacist intervention to deprescribe inappropriate aspirin therapy in an outpatient anticoagulation clinic at a community hospital. Am Heart J Plus 17:100165. https:\/\/doi.org\/10.1016\/j.ahjo.2022.100165","journal-title":"Am Heart J Plus"},{"issue":"9","key":"3283_CR31","doi-asserted-by":"publisher","first-page":"e2231973","DOI":"10.1001\/jamanetworkopen.2022.31973","volume":"5","author":"JK Schaefer","year":"2022","unstructured":"Schaefer JK, Errickson J, Gu X et al (2022) Assessment of an intervention to reduce aspirin prescribing for patients receiving warfarin for anticoagulation. JAMA Netw Open 5(9):e2231973. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.31973","journal-title":"JAMA Netw Open"},{"issue":"16","key":"3283_CR32","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1056\/NEJMoa2507532","volume":"393","author":"G Lemesle","year":"2025","unstructured":"Lemesle G, Didier R, Steg PG et al (2025) Aspirin in patients with chronic coronary syndrome receiving oral anticoagulation. N Engl J Med 393(16):1578\u20131588. https:\/\/doi.org\/10.1056\/NEJMoa2507532","journal-title":"N Engl J Med"},{"issue":"4","key":"3283_CR33","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/CIRCULATIONAHA.125.077141","volume":"153","author":"G Lemesle","year":"2026","unstructured":"Lemesle G, Didier R, Diallo A et al (2026) Anticoagulation and antiplatelet therapy versus anticoagulation alone in patients with chronic coronary syndrome receiving long-term anticoagulation: a meta-analysis of randomized clinical trials. Circulation 153(4):294\u2013296. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.125.077141","journal-title":"Circulation"},{"issue":"3","key":"3283_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40266-023-01006-8","volume":"40","author":"E Philippe","year":"2023","unstructured":"Philippe E, Henrard S, Boland B, Marien S (2023) Inappropriate combined antiplatelet and anticoagulant therapy in older patients with atrial fibrillation: trend over time (2009-18). Drugs Aging 40(3):273\u2013283. https:\/\/doi.org\/10.1007\/s40266-023-01006-8","journal-title":"Drugs Aging"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03283-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03283-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03283-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:15:56Z","timestamp":1786007756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03283-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["3283"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03283-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8081005\/v1","asserted-by":"object"}]},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}